Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPM.L Regulatory News (MPM)

  • There is currently no data for MPM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes

23 Feb 2018 07:00

RNS Number : 7155F
mporium Group PLC
23 February 2018
 

23 February 2018

Mporium Group plc 

 

("Mporium" or the "Company") 

 

Board Changes

 

Mporium Group plc (AIM:MPM), the technology firm delivering event-driven marketing, is pleased to announce the appointment of Nicholas Bertolotti as Non-Executive Director of the Company.

 

Nick has spent over 25 years advising companies in the Technology, Media and Telecoms ("TMT") sector. From 2003 to 2016 he was a Managing Director in Investment Banking at Credit Suisse, where he headed up the European Media Equity Research team, and where he was voted many times the number one rated European media analyst in the Extel and Institutional Investor surveys. He joined Credit Suisse from JPMorgan, where he spent seven years, latterly as a Managing Director and head of the European Media Equity Research team.

 

Prior to this Nick worked at Arthur Andersen (now Deloitte) as a Partner in Financial Consulting Services advising primarily TMT companies on strategy, operations, marketing, international expansion, M&A, investment and valuation. He holds a BSc degree in Economics and Accounting from the University of Bristol (1983), qualified as an ACA Chartered Accountant in 1987 and has an MBA from Cambridge University Judge Business School (1992).

 

The Group also announces that Staale Bjornstad, Non-Executive Director, will be stepping down from the Board with immediate effect. Since joining the Board in June 2015, Staale has provided valuable insight to the business and strong support in the development of its proprietary technology. The Board thanks Staale for his significant contribution and wishes him the best in his future endeavours.

 

Barry Moat, Chairman of Mporium, said:

 

"I am delighted that Nick has agreed to join the Board. With his unrivalled sector experience, his appointment speaks volumes of the quality of our technology and market opportunity. As well as being able to draw on Nick's vast experience in his counsel to the Board, he will also provide unrivalled access to the contacts that he has built over the last 25 years in the Media and Tech industries and in the general financial markets."

 

Other Information 

 

In relation to the appointment of Mr Bertolotti, the Company confirms that there is no further information to be disclosed under paragraph (g) of Schedule 2 of the AIM Rules for Companies save as disclosed below:

 

Full Name:

Nicholas Bertolotti

Age:

55

Current Directorships /Partnerships

Previous Directorships

None

Telemetry Limited

Enquiries

 

Mporium:

020 3841 8411

Nelius De Groot, Chief Executive Officer

N+1 Singer:

020 7496 3000

Mark Taylor

Michael Taylor

Alex Laughton-Scott

Alma PR:

020 3865 9668

Rebecca Sanders-Hewett

Josh Royston

Susie Hudson

Sam Modlin

 

Notes to editors

 

About Mporium

 

Mporium is a technology company at the forefront of the transformation in digital marketing. Mporium's proprietary technology enables advertisers, to identify and monetise micro-moments - those moments when there are significant changes in the levels of consumer intent. Using technologies derived from financial services, these micro-moments are used to drive highly performant digital advertising campaigns: from brand advertising to direct response.

 

Based in the UK, Mporium Group plc is quoted on AIM, the junior market of the London Stock Exchange plc.

 

www.mporium.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOATTMPTMBBTBRP
Date   Source Headline
6th Jun 20147:00 amRNSAGM Statement
23rd May 20147:00 amRNSContract wins
22nd May 20145:00 pmRNSCompletion of audit
21st May 20145:06 pmRNSAnnual General Meeting
13th May 20147:00 amRNSResults for year ended 31 December 2013
29th Apr 201411:30 amRNSNotice of results & new product launch
31st Mar 20147:00 amRNSTOTAL VOTING RIGHTS
21st Mar 20147:00 amRNSAgreement with Affiliate Window
12th Mar 20143:39 pmRNSDirector/PDMR Shareholding
11th Mar 20144:35 pmRNSBlock Admission Application
7th Mar 20147:00 amRNSNew Customer and Sector Wins
20th Jan 20147:00 amRNSPRE-CLOSE TRADING UPDATE
17th Jan 201410:17 amRNSHoldings in Company
18th Dec 20137:00 amRNSFirst Day of Dealings
5th Mar 20107:00 amRNSOffer Update
5th Mar 20107:00 amRNSCompulsory Acquisition of Minster Shares
17th Feb 20107:14 amRNSBoard Changes, Issue of Deferred Consideration
17th Feb 20107:00 amRNSOffer Update
1st Feb 201012:50 pmRNSDirectorate Change
25th Jan 20105:51 pmRNSEPT Disclosure
20th Jan 201011:59 amRNSRule 8.3- Minster Pharmaceuticals PLC
14th Jan 20104:00 pmRNSPosting of Offer Document
14th Jan 20104:00 pmRNSPosting of Offer Document
13th Jan 20102:27 pmRNSRule 8.3- Minster Pharma PLC
4th Jan 20103:11 pmRNSAcquisition of Minster Pharmaceuticals
4th Jan 20103:11 pmRNSCash Offer
20th Nov 20097:00 amRNSInterim Results
21st Sep 20097:00 amRNSDirectorate Change
15th Sep 20093:31 pmRNSChange of Registered Office
14th Sep 20097:00 amRNSTonabersat at IHS Congress
23rd Jul 20097:00 amRNSSabcomeline Patent Filing
17th Jul 200910:39 amRNSDirector/PDMR Shareholding
6th Jul 20097:00 amRNSPublication of Aura Results
30th Jun 200911:30 amRNSResult of AGM
30th Jun 20097:01 amRNSAGM Statement
30th Jun 20097:00 amRNSRajinder Kumar Appointment
2nd Jun 20095:04 pmRNSAnnual Financial Report
29th May 200910:51 amRNSGrant of Share Option to Director
29th May 200910:47 amRNSDirector/PDMR Shareholding
28th May 20097:00 amRNSPreliminary Results
20th Apr 20097:00 amRNSKarl Keegan appointed CFO
17th Apr 20097:16 amRNSDirectorate Change
11th Feb 20093:39 pmRNSHolding(s) in Company
2nd Feb 20097:00 amRNSTempus Study Results
18th Dec 200811:52 amRNSHolding(s) in Company
4th Dec 20087:00 amRNSUS Licensing Consultant
14th Nov 20087:00 amRNSInterim Results
11th Nov 20087:00 amRNSNotice of Interim Results
22nd Oct 20087:00 amRNSPositive Phase II Results
30th Jun 20087:00 amRNSSymposium at AHS Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.